MediWound Ltd. (MDWD)
NASDAQ: MDWD · Real-Time Price · USD
16.65
-0.13 (-0.77%)
Nov 21, 2024, 12:56 PM EST - Market open
MediWound Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for MediWound stock has a target of 28, which predicts an increase of 68.17% from the current stock price of 16.65.
Analyst Consensus: Strong Buy
* Price targets were last updated on Oct 11, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for MediWound is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +68.17% | Oct 11, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +68.17% | Aug 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +68.17% | Jul 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +68.17% | May 30, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +68.17% | Mar 22, 2024 |
Financial Forecast
Revenue This Year
24.32M
from 18.69M
Increased by 30.16%
Revenue Next Year
28.81M
from 24.32M
Increased by 18.44%
EPS This Year
-2.72
from -0.75
EPS Next Year
-2.26
from -2.72
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 25.2M | 30.0M | 55.2M | ||
| Avg | 24.3M | 28.8M | 41.8M | ||
| Low | 23.0M | 27.4M | 34.3M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 34.9% | 23.2% | 91.5% | ||
| Avg | 30.2% | 18.4% | 45.0% | ||
| Low | 23.2% | 12.8% | 19.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -2.67 | -1.70 | -1.05 | ||
| Avg | -2.72 | -2.26 | -1.07 | ||
| Low | -2.74 | -2.72 | -1.08 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.